Autor: Firma Omnix Medical

Omnix Medical Starts Phase I Clinical Trial of Novel Anti-Infective; First Healthy Volunteers Dosed

12. April 202212. April 2022 Firma Omnix MedicalAllgemeinbaumannii, cell, clinical, dosing, eic, medical, new, ofa, omn6, omnix, patients, placebo, research, treatment, with

Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for the treatment of life-threatening infections, today announced the initiation of a Dutch Phase I clinical trial with its lead compound OMN6. Since March 28, 2022, six healthy volunteers have been administered Mehr

Omnix Medical Wins €10.8M in EIC Accelerator Funding

25. Januar 202131. August 2021 Firma Omnix MedicalAllgemeinaccelerator, award, board, clinical, drugs, eic, lethal, market, medical, new, patients, peptide, research, treatment, with

Novel class of anti-infectives fighting hospital-associated infections and multi-drug resistant bacteria Lead program OMN6 to be advanced to proof-of-concept in humans Antonius Schuh appointed as Chairman of the Board of Directors Omnix Medical, a Jerusalem-based biopharmaceutical company developing next-generation anti-infectives Mehr